3.37
Finanzdaten der Ironwood Pharmaceuticals Inc-Aktie (IRWD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
60.91%
47.71
|
122.06 | 85.24 | 41.14 | 90.55 |
|
|
12.18%
40.90
|
46.58 | 39.92 | 70.25 | 59.05 |
| Benefits Costs and Expenses |
12.18%
40.90
|
46.58 | 39.92 | 70.25 | 88.29 |
| Costs And Expenses |
12.18%
40.90
|
46.58 | 39.92 | 70.25 | 59.05 |
| Operating Income/Loss |
90.98%
6.805
|
75.48 | 45.32 | -29.11 | 31.49 |
| Nonoperating Income/Loss |
14.92%
-6.35
|
-7.464 | -7.499 | -7.164 | -7.496 |
| Income/Loss From Continuing Operations Before Tax |
90.00%
6.805
|
68.02 | 37.82 | -36.27 | 2.256 |
| Income Tax Expense/Benefit |
90.23%
2.731
|
27.94 | 14.22 | 1.114 | 21.74 |
| Income/Loss From Continuing Operations After Tax |
105.68%
-2.276
|
40.08 | 23.60 | -37.39 | 2.256 |
|
|
105.68%
-2.276
|
40.08 | 23.60 | -37.39 | 2.256 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.88%
0.20
|
162.22 | 161.72 | 160.97 | 0.273 |
| Diluted Average Shares |
107.92%
-14.07
|
177.76 | 176.84 | 160.97 | 1.274 |
| Basic Earnings Per Share |
104.00%
-0.01
|
0.25 | 0.15 | -0.23 | 0.01 |
| Diluted Earnings Per Share |
104.35%
-0.01
|
0.23 | 0.14 | -0.23 | 0.01 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):